The University actively supports researchers and academic staff in the creation of new ventures to bring new ideas and breakthrough innovations to market. This support ranges from licensing IP, connecting with investors and partners and facilitating the creation of spinout companies. If you are interested in finding out more about our pipeline of spinout companies and how you could get involved please contact: Morven Fraser-Walther, Head of IP & Commercialisation: Morven.Fraser-Walther@glasgow.ac.uk University of Glasgow: Venture Portfolio Aurum Biosciences develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need with an initial indication in stroke. Causeway Therapeutics Ltd has developed a microRNA therapy for the treatment of tendinopathy in human (TenoMiR) and equine (EquiMiR) patients. CENSIS is a technology innovation and venture-delivery organisation that builds, deploys and scales applied digital products and services. Chemify will digitize chemistry and produce robotic solutions to run chemical code for drug discovery, chemical synthesis, and materials discovery Clyde Biosciences provides new instrumentation and services for cell-based (including stem cell) testing for early detection of toxicity in drug discovery. Clyde Hydrogen Systems has redefined the architecture for the next generation of green hydrogen production systems. The company has developed a new type of electrolysis that allows hydrogen and oxygen to be made in separate places and at different times and rates. DeepMatter is a big data and analysis company which has built a platform focused on enabling reproducibility in chemistry. The company is at the forefront of the digitization of chemistry. Design Otherwise bridges research, policy and practice to create lasting change in the cultural economy. We transform diversity insights into impactful, everyday solutions. Entourage AI leverages AI-powered proteomics to analyze your blood, translating complex biomarker data into a personalized, actionable plan for optimizing health span and longevity Glanadair Ltd., cold plasma decontamination: Specialising in surface decontamination using patented plasma-generated ozone technology for improved efficiency. Pioneering the development of Precision Antibiotics to combat Antimicrobial Resistance. Wafer Design, Manufacturing, Test and Characterisation. III-V Epi provides a range of compound semiconductor wafer foundry services, specialising in the manufacture of low to medium volume, MBE and MOCVD, III-V, epitaxial structures and overgrowth for compound semiconductor device applications. Intense uses propietary technology and processes to create diode laser products with unrivalled levels of power, brightness and reliability. Keltic Pharma Therapeutics Ltd delivers translational programs for new medicines to cure and block transmission of the human malarial parasite and address unmet clinical needs in respiratory lung disease and neuropsychiatric disorders. Kelvin Nanotechnology provides nanofabrication design and manufacturing services specialising in high resolution, electron beam lithography. Creating Cryo-capable electronics for your quantum applications: Kelvin Quantum’s Systems are capable of operation from room to deep cryogenic temperatures. KEPsoft Collaborative is a not-for-profit social enterprise providing software and services for national and international kidney exchange programmes. Lynkeos Technology develops imaging systems to inspect the contents of complex, shielded structures. Unlocking the Future of Ultrasonic Surgery: Nami Surgical have developed an innovative solution to drawbacks present in existing scalpels used in robot assisted surgery today. NebuFlow unlocks delivery of the next generation of inhaled drugs for patients with widespread respiratory disorders, the main cause of death and disability worldwide. Pushing the boundaries of innovation in Tunneling Magnetoresistance (TMR) quantum sensing by developing custom semiconductor designs and AI-enabled hardware and software solutions. High-quality, state-of-the-art quantum components: Quantcore devices operate at higher temperatures, lowering the energy requirements and barriers to electronic integration - improving prospects for scaling. Seamless recharging & maintenance-free sensing using long-range wireless RF power and data transfer and sensing. Semiwise offers low power complementary metal-oxide-semiconductor (CMOS) technology that has the power to revolutionise the Internet of Things (IoT) and Artificial Intelligence (AI). Solasta Bio is a nature-inspired insecticides discovery company focused on creating peptide-based insecticides that meet the global need for effective, new insect control products that are friendly to the environment and preserve beneficial insects such as bees. Providing advanced semiconductor probe needle solutions to the probe card market. Thermoelectric Conversion Systems Ltd (TCS) is a UK-based clean tech company pioneering the next generation of heat pumps using solid-state thermoelectric technology. TileBio is pioneering a new class of AI pathology foundation models that self-learn a universal visual language of tissue, without human input. This is transforming clinical diagnostics, biomarker discovery and target development. Vector Photonics produces PCSEL (Photonic Crystal Surface Emitting Laser), semiconductor lasers – the most significant innovation in laser design and manufacture for 30 years. The next generation of analog and RF design automation Acquired companies A number of our spinout companies and technologies have been acquired, recognising the growth potential of the companies and the impact of their technologies and services. - Kelvin Connect, a spin-out which specialised in mobile data capture systems - acquired by the UK emergency services’ communications provider Airwave Solutions Limited. - Gold Standard Simulations, a spin-out which specialised in advanced simulation tools for the semiconductor industry - acquired by Synopsys, a US-based chip design software company specialising in electronic design automation and semiconductor IP. - ReactivLab, a spin-out which developed animal health diagnostic technology - acquired by the Avacta Group which through its subsidiary, Avacta Animal Health, provided an established route to the veterinary market in the UK, EU and worldwide. - Kymata, an optical components company built on University of Glasgow technology - acquired by Gemfire, an optical components group. - Virttu Biologics, a spin-out which pioneered the development of oncolytic viruses for treating cancer - acquired by Sorrento Therapeutics, a clinical stage biopharmaceutical company developing new treatments for immuno-oncology, inflammation and autoimmune diseases.
